Cathepsin G, a Neutrophil Protease, Induces Compact Cell-Cell Adhesion in MCF-7 Human Breast Cancer Cells

Mediators of Inflammation - Tập 2009 - Trang 1-11 - 2009
Tomoya Kudo1, Hideaki Kigoshi1, Takashi Hagiwara1, Takahisa Takino2, Masatoshi Yamazaki1, Satoru Yui1
1Faculty of Pharmaceutical Sciences, Teikyo University, 1091-1 Sagamiko, Sagamihara, Kanagawa 229-0195, Japan
2Department of Molecular Virology and Oncology, Cancer Research Institute, Kanazawa University, 13-1 Takara-machi, Kanazawa, 920-0934, Japan

Tóm tắt

Cathepsin G is a serine protease secreted by activated neutrophils that play a role in the inflammatory response. Because neutrophils are known to be invading leukocytes in various tumors, their products may influence the characteristics of tumor cells such as the growth state, motility, and the adhesiveness between cells or the extracellular matrix. Here, we demonstrate that cathepsin G induces cell-cell adhesion of MCF-7 human breast cancer cells resulting from the contact inhibition of cell movement on fibronectin but not on type IV collagen. Cathepsin G subsequently induced cell condensation, a very compact cell colony, resulting due to the increased strength of E-cadherin-mediated cell-cell adhesion. Cathepsin G action is protease activity-dependent and was inhibited by the presence of serine protease inhibitors. Cathepsin G promotes E-cadherin/catenin complex formation and Rap1 activation in MCF-7 cells, which reportedly regulates E-cadherin-based cell-cell junctions. Cathepsin G also promotes E-cadherin/protein kinase D1 (PKD1) complex formation, and Go6976, the selective PKD1 inhibitor, suppressed the cathepsin G-induced cell condensation. Our findings provide the first evidence that cathepsin G regulates E-cadherin function, suggesting that cathepsin G has a novel modulatory role against tumor cell-cell adhesion.

Từ khóa


Tài liệu tham khảo

1982, Journal of Clinical Investigation, 69, 384, 10.1172/JCI110462

1984, Journal of Immunology, 132, 2547, 10.4049/jimmunol.132.5.2547

1990, Journal of Immunology, 143, 2961

1987, Biochemistry, 26, 2289, 10.1021/bi00382a032

2005, Journal of Internal Medicine, 257, 319, 10.1111/j.1365-2796.2005.01476.x

1975, Journal of Clinical Investigation, 56, 1118, 10.1172/JCI108186

10.1111/j.1349-7006.2005.00097.x

1989, Proceedings of the National Academy of Sciences of the United States of America, 86, 5859, 10.1073/pnas.86.15.5859

2003, American Journal of Pathology, 163, 2221, 10.1016/S0002-9440(10)63580-8

1991, Science, 251, 1451, 10.1126/science.2006419

1987, Trends in Genetics, 3, 213, 10.1016/0168-9525(87)90238-1

1988, Cell, 54, 993, 10.1016/0092-8674(88)90114-6

10.1073/pnas.91.1.206

1987, Journal of Cell Biology, 105, 2501, 10.1083/jcb.105.6.2501

1990, Journal of Cell Biology, 110, 1239, 10.1083/jcb.110.4.1239

1988, EMBO Journal, 7, 3679, 10.1002/j.1460-2075.1988.tb03249.x

1989, EMBO Journal, 8, 1711, 10.1002/j.1460-2075.1989.tb03563.x

1992, Journal of Cell Biology, 116, 989, 10.1083/jcb.116.4.989

10.1016/0092-8674(90)90506-A

10.1073/pnas.92.19.8813

1994, Journal of Cell Science, 107, 3655, 10.1242/jcs.107.12.3655

10.1073/pnas.92.11.5067

10.1083/jcb.142.4.1105

10.1038/nrm2457

1996, Physiological Reviews, 76, 69, 10.1152/physrev.1996.76.1.69

1988, Journal of Cell Biology, 107, 1575, 10.1083/jcb.107.4.1575

10.1242/jcs.03306

10.1128/MCB.24.15.6690-6700.2004

1997, Oncogene, 15, 1283, 10.1038/sj.onc.1201296

2005, Cancer Research, 65, 483, 10.1158/0008-5472.483.65.2

10.1016/0014-5793(96)00785-5

1992, Journal of Medicinal Chemistry, 35, 177, 10.1021/jm00079a024

1995, Circulation, 91, 1872, 10.1161/01.CIR.91.6.1872

10.1074/jbc.270.19.11168

10.1038/nature01322

10.1158/0008-5472.CAN-07-2938

10.1387/ijdb.041821pf

10.1038/nrc1075

10.1016/j.ceb.2003.11.001

10.1074/jbc.273.27.16953

10.1074/jbc.275.10.6819